LobbyingRiveria Investment Group on Behalf of on the Right Track lobbying by quarter
Riveria Investment Group on Behalf of on the Right Track's latest lobbying report covers Q2 2026, at $30K. The four quarters Q4 2025–Q3 2026 total $90K. Its first report covers Q3 2025; the issues it reports most are Medical/Disease Research/Clinical Labs and Miscellaneous Tariff Bills.
Riveria Investment Group on Behalf of on the Right Track
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $90K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q3 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q3 2025 | $20K | 1 |
| Q4 2025 | $30K | 1 |
| Q1 2026 | $30K | 1 |
| Q2 2026 | $30K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Medical research and clinical labs$65K · 4 reports
- Tariffs$45K · 3 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES4 reports
- SENATE3 reports
- U.S. Trade Representative (USTR)3 reports
- Commerce, Dept of (DOC)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Holland & Knight | $110K | 4 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/07for Q2 | Holland & Knight | $30K |
| 04/20for Q1 | Holland & Knight | $30K |
| 01/15for Q4 2025 | Holland & Knight | $30K |
| 25/10/18for Q3 2025 | Holland & Knight | $20K |
| 25/10/03for Q3 2025 | Holland & Knight | Under $5,000 |